Week of July 5, 2023 | Vol. 12, Issue 26

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Shionogi takes antibiotic maker under its wing in $100M cash buyout

Endpoints News - Jun 26, 2023

UnitedHealth wins $3.3 billion takeover of home health giant Amedisys

Stat News - Jun 26, 2023

Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies

Business Wire - Jun 26, 2023

Sutro Biopharma and Blackstone Announce Royalty Financing Collaboration

Globe Newswire - Jun 26, 2023

Xentria and Meitheal ink licensing deal for rare lung disease treatment in North America

Endpoints News - Jun 27, 2023

Companies are right to embrace artificial intelligence - not doing so is 'no longer an option' says eClinical Solutions

Outsourcing Pharma - Jun 26, 2023

New Hope Research Foundation and Forge Biologics Announce cGMP Manufacturing Partnership to Accelerate Gene Therapy for Patients with Tay-Sachs Disease

Forge Biologics - Jun 28, 2023

Lilly to Acquire Diabetes Cell Therapy Company Sigilon Therapeutics

Contract Pharma - Jun 29, 2023

Societal CDMO signs master service agreement with CivicaScript to provide CDMO services

Societal CDMO - Jun 29, 2023

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

BioSpace - Jun 30, 2023

TANNER NEWS

The Benefits of Early Access Programs

Patients living with critical illnesses may require access to medicines that are unavailable to them for various reasons. Life-changing treatments might take years to pass the necessary regulatory approvals in certain countries, if at all. Tanner enables patient access to innovative medicines through the creation and implementation of early access programs. Read more.